Guardant Health Inc. Common Stock vs Navan Inc. Class A Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $167.06 (market cap $22.22B), while Navan Inc. Class A Common Stock trades at $23.62 (market cap $6.01B). The key difference: Guardant Health Inc. Common Stock is far larger — about 3.7× Navan Inc. Class A Common Stock's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Navan Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and Navan Inc. Class A Common Stock for 1 Days on average.
| GH | NAVN | |
|---|---|---|
Market Cap | $22.22B | $6.01B |
Volume | 1,589,453 | 2,990,425 |
Sector | Health | Technology |
52-Week High | $187.22 | $30.58 |
52-Week Low | $61.73 | $8.51 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $22.86B | $5.36B |
Trailing returns across standard periods
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →